• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risks in new drug development: approval success rates for investigational drugs.

作者信息

Dimasi J A

机构信息

Director of Economic Analysis, Tufts Center for the Study of Drug Development, Tufts University, Boston, MA 02111, USA.

出版信息

Clin Pharmacol Ther. 2001 May;69(5):297-307. doi: 10.1067/mcp.2001.115446.

DOI:10.1067/mcp.2001.115446
PMID:11371997
Abstract
摘要

相似文献

1
Risks in new drug development: approval success rates for investigational drugs.新药研发中的风险：研究性药物的获批成功率
Clin Pharmacol Ther. 2001 May;69(5):297-307. doi: 10.1067/mcp.2001.115446.
2
Trends in risks associated with new drug development: success rates for investigational drugs.新药研发相关风险趋势：研究药物的成功率。
Clin Pharmacol Ther. 2010 Mar;87(3):272-7. doi: 10.1038/clpt.2009.295. Epub 2010 Feb 3.
3
Market failure and the poverty of new drugs in maternal health.市场失灵与孕产妇保健新药匮乏
PLoS Med. 2008 Jan 22;5(1):e22. doi: 10.1371/journal.pmed.0050022.
4
The FDA Breakthrough-Drug Designation - Four Years of Experience.美国食品药品监督管理局突破性药物认定——四年经验
N Engl J Med. 2018 Apr 12;378(15):1444-1453. doi: 10.1056/NEJMhpr1713338.
5
New drug development in the United States from 1963 to 1999.1963年至1999年美国的新药研发情况。
Clin Pharmacol Ther. 2001 May;69(5):286-96. doi: 10.1067/mcp.2001.115132.
6
Drug pipeline: 3Q15.药物研发进程：2015年第三季度。
Nat Biotechnol. 2015 Nov;33(11):1126. doi: 10.1038/nbt.3405.
7
New estimates of drug development costs.药物研发成本的新估计。
J Health Econ. 2003 Mar;22(2):325-30. doi: 10.1016/S0167-6296(03)00002-X.
8
Clinical approval success rates for investigational cancer drugs.癌症药物临床试验的审批成功率。
Clin Pharmacol Ther. 2013 Sep;94(3):329-35. doi: 10.1038/clpt.2013.117. Epub 2013 Jun 5.
9
Obstacles and opportunities in new drug development.新药研发中的障碍与机遇。
Clin Pharmacol Ther. 2008 Feb;83(2):210-2. doi: 10.1038/sj.clpt.6100462.
10
The COPD Pipeline.慢性阻塞性肺疾病（COPD）研发管线
COPD. 2009 Dec;6(6):488-9. doi: 10.3109/15412550903368417.

引用本文的文献

1
Disease foci of pharmaceutical research and development as reflected in applications for International Nonproprietary Names, 1953-2022.1953年至2022年国际非专利药名申请中反映的药物研发疾病重点领域
Bull World Health Organ. 2025 Jan 1;103(1):9-18. doi: 10.2471/BLT.23.291203. Epub 2024 Nov 4.
2
Impact of Growth Conditions on High-Throughput Identification of Repurposing Drugs for Cystic Fibrosis Lung Infections.生长条件对囊性纤维化肺部感染药物再利用高通量鉴定的影响。
Antibiotics (Basel). 2024 Jul 12;13(7):642. doi: 10.3390/antibiotics13070642.
3
Shining a light on liver health: advancements in fluorescence-enhanced enzyme biosensors for early disease detection.
聚焦肝脏健康：用于早期疾病检测的荧光增强酶生物传感器的进展
Front Bioeng Biotechnol. 2024 Apr 19;12:1392857. doi: 10.3389/fbioe.2024.1392857. eCollection 2024.
4
The Experimentalist's Guide to Machine Learning for Small Molecule Design.小分子设计机器学习的实验者指南。
ACS Appl Bio Mater. 2024 Feb 19;7(2):657-684. doi: 10.1021/acsabm.3c00054. Epub 2023 Aug 3.
5
Repurposing High-Throughput Screening Identifies Unconventional Drugs with Antibacterial and Antibiofilm Activities against Pseudomonas aeruginosa under Experimental Conditions Relevant to Cystic Fibrosis.重新利用高通量筛选技术，在与囊性纤维化相关的实验条件下，发现对铜绿假单胞菌具有抗菌和抗生物膜活性的非传统药物。
Microbiol Spectr. 2023 Aug 17;11(4):e0035223. doi: 10.1128/spectrum.00352-23. Epub 2023 Jun 12.
6
Discovery of new 5-substituted-indole-2-carboxamides as dual epidermal growth factor receptor (EGFR)/cyclin dependent kinase-2 (CDK2) inhibitors with potent antiproliferative action.新型5-取代吲哚-2-甲酰胺作为双表皮生长因子受体（EGFR）/细胞周期蛋白依赖性激酶-2（CDK2）抑制剂的发现及其强效抗增殖作用
RSC Med Chem. 2023 Mar 16;14(4):734-744. doi: 10.1039/d3md00038a. eCollection 2023 Apr 26.
7
Predictive validity in drug discovery: what it is, why it matters and how to improve it.药物发现中的预测有效性：是什么，为什么重要以及如何提高它。
Nat Rev Drug Discov. 2022 Dec;21(12):915-931. doi: 10.1038/s41573-022-00552-x. Epub 2022 Oct 4.
8
An overview of Fintech applications to solve the puzzle of health care funding: state-of-the-art in medical crowdfunding.金融科技应用于解决医疗保健资金难题的概述：医疗众筹的最新进展。
Financ Innov. 2022;8(1):84. doi: 10.1186/s40854-022-00388-9. Epub 2022 Sep 19.
9
A UPLC-MS/MS application for comparisons of the hepatotoxicity of raw and processed Xanthii Fructus by energy metabolites.一种通过能量代谢物比较生熟苍耳子肝毒性的超高效液相色谱-串联质谱联用应用。
RSC Adv. 2019 Jan 21;9(5):2756-2762. doi: 10.1039/c8ra08272c. eCollection 2019 Jan 18.
10
Repurposing approved therapeutics for new indication: Addressing unmet needs in psoriasis treatment.将已获批的治疗药物用于新适应症：满足银屑病治疗中未被满足的需求。
Curr Res Pharmacol Drug Discov. 2021 Jun 9;2:100041. doi: 10.1016/j.crphar.2021.100041. eCollection 2021.